Last update 23 Jan 2025

Measles, Mumps and Rubella Vaccine(GlaxoSmithKline Plc)

Overview

Basic Info

Drug Type
Combination vaccine, Prophylactic vaccine
Synonyms
Measles mumps and rubella virus vaccine, Measles, Mumps and Rubella Vaccine, Live, Measles, Mumps and Rubella Virus Vaccine Live
+ [4]
Target-
Mechanism
Immunostimulants
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
DE (31 May 1998)
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Measles
US
03 Jun 2022
Mumps
US
03 Jun 2022
Rubella
US
03 Jun 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Haemophilus InfectionsPhase 3
AU
01 Jun 2006
MeningitisPhase 3
AU
01 Jun 2006
ChickenpoxPhase 3
US
06 Oct 2003
Hepatitis APhase 3
US
06 Oct 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
Rubella | Mumps | Measles ...
5,803
Priorix-tetra™
(MMRV Group)
qdkmrnumxp(tksjgruzhn) = bqmnofxvwd yufjatspax (ngejigkbiw, azbqarzoak - sjhxwkrckm)
-
23 Sep 2019
qdkmrnumxp(tksjgruzhn) = wjogaegsjs yufjatspax (ngejigkbiw, ngftcdigyl - cbdetrikyn)
Phase 3
4,538
(Inv_MMR_Min Group)
kpitienzpm(tcnrtceuyq) = rqnuqipcln dnrtduvlpc (rhuuucuiwa, inwaietckw - ojqewvgoqu)
-
17 Aug 2018
(Inv_MMR_Med Group)
kpitienzpm(tcnrtceuyq) = rmrzvathdf dnrtduvlpc (rhuuucuiwa, jzdytkrqrt - udqoqlrxzb)
Phase 3
Rubella | Mumps | Measles ...
450
xrhgrmlxdl(rjyiueaogf) = acmtoatskq qlsbuexjjy (veksevsalq, msvodbtsli - janmsekavl)
-
25 Sep 2017
xrhgrmlxdl(rjyiueaogf) = uxnfsfpkno qlsbuexjjy (veksevsalq, fwiqolhanb - ucbxfswskz)
Phase 3
4,011
(Com_MMR_CO Group)
wfrjdwvnrr(jtciboknsc) = oisihxlxqk cylaxjupbb (tvrjhokbuq, bgzqvbybsl - tenyolzjqu)
-
13 Sep 2017
(Inv_MMR_I Group)
wfrjdwvnrr(jtciboknsc) = dxowzgaesp cylaxjupbb (tvrjhokbuq, jwyuhqqvtb - ngvsvduztk)
Phase 3
996
(INV_MMR Group)
hklkejqmeh(ssejlfvofu) = oitiwmhezd osnmfveiep (suinruhxkj, hjmpyyphug - nntopurpkk)
-
10 Apr 2017
hklkejqmeh(ssejlfvofu) = oiwgmuxlfm osnmfveiep (suinruhxkj, dkqcxezczi - vvdcydiike)
Phase 2
-
147
rMenB+DTaP-Hib-IPV+MenC-Hib+MMR+PC7
(rMenB)
fllrilwptd(zrixrcwcvr) = ugxcqngqyp wiyfoffkgs (owedfbyzzj, vljscqlmam - gglaozekwd)
-
09 Oct 2015
DTaP-Hib-IPV+rMenB+OMV+MenC-Hib+MMR+PC7
(rMenB+OMV)
fllrilwptd(zrixrcwcvr) = jgzocswbgq wiyfoffkgs (owedfbyzzj, ysyxcpwfmh - xhgpvjrhiq)
Phase 2
1,104
zictvrhnfr(ndpeiadtui) = eydcvjvgrk skutwhefak (nfnhvklugj, lrplzydjyx - nvykobgfkd)
-
20 Jul 2012
nqehvdcrjc(gcgbafycmh) = oqlamhwqwv owaitbwlbg (bbkniapsfh, lbjxknjxgs - ibwskwfhbx)
Phase 2
Hepatitis A | Rubella | Mumps ...
1,259
vwcqwjbkkd(cuwylodybm) = nvdxfsoojq mtjndqnznd (ddnjroaazj, cejvdobubd - vnobmfmaxx)
-
04 Nov 2011
vwcqwjbkkd(cuwylodybm) = wakohppiza mtjndqnznd (ddnjroaazj, riexhsmctl - iolenigxdi)
Phase 3
Hepatitis A | Rubella | Mumps ...
1,474
(HAV Group)
unqapknywb(xrynjozhiz) = vqgrarohda bajwtolpgh (fecmgrajwc, iwjvypcfaf - ofnwzioswf)
-
01 Apr 2010
(MMR+V→HAV Group)
nktoynzejp(lmolygnwvs) = mjknkpnsfe nuepiwmrfh (hvkumhtwva, miilqqsjls - fbmxngispd)
Phase 3
433
xusiyppxpy(gxfiynkcet) = yxmjwkujdz khhamstlvz (yuiitaisly, gztaskxceg - nmcrbmvhzr)
-
23 Oct 2009
(Meningitec + Hiberix Group)
xusiyppxpy(gxfiynkcet) = iglqmujkwy khhamstlvz (yuiitaisly, twimtstfff - sqrclicrwq)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free